CRNX R&D Expenses
Crinetics Pharmaceuticals Inc · R&D Expenses
CRNX R&D Expenses
Latest reported$375.45Mperiod ending
CRNX TTM R&D Expenses ($9.23M → $375.45M)
TTM R&D Expenses
High-resolution chart · PNG
CRNX r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 375,448,000 | |
| 355,899,000 | |
| 332,058,000 | |
| 313,571,000 | |
| 285,012,000 | |
| 263,055,000 | |
| 240,156,000 | |
| 219,213,000 | |
| 201,147,000 | |
| 183,443,000 | |
| 168,570,000 | |
| 159,938,000 | |
| 148,086,000 | |
| 140,441,000 | |
| 130,225,000 | |
| 117,838,000 | |
| 107,531,000 | |
| 95,223,000 | |
| 84,610,000 | |
| 76,836,000 | |
| 68,855,000 | |
| 60,775,000 | |
| 56,998,000 | |
| 52,311,000 | |
| 50,435,000 | |
| 48,113,000 | |
| 41,506,000 | |
| 37,014,000 | |
| 32,077,000 | |
| 27,014,000 | |
| 24,479,000 | |
| 19,390,000 | |
| 15,027,000 | |
| 11,888,000 | |
| 9,233,000 |